Tailored endpoints: A proposal for design of future clinical trials in metastatic breast cancer (MBC).

Caterina Fontanella,Marta Bonotto,Pamela Driol,Francesca Valent,Lorenzo Gerratana,Stefania Russo,Claudia Andreetta,Alessandro Marco Minisini,M. Mansutti,Roberta Sottile,Gianpiero Fasola,Fabio Puglisi

Tailored endpoints: A proposal for design of future clinical trials in metastatic breast cancer (MBC).

2012

Caterina Fontanella
Marta Bonotto
Pamela Driol
Francesca Valent
Lorenzo Gerratana
Stefania Russo
Claudia Andreetta
Alessandro Marco Minisini
M. Mansutti
Roberta Sottile
Gianpiero Fasola
Fabio Puglisi

e13058 Background: Widespread access to active agents against MBC has produced significant improvements in survival, even though few phase III trials are powered to detect overall survival (OS) eff...

Keywords:

Clinical trial
Pathology
Medicine
Metastatic breast cancer
Internal medicine
phase iii trials
overall survival
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations